Skip to main content
Annals of Intensive Care
Fig. 3 | Annals of Intensive Care

Fig. 3

From: Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study

Fig. 3

Survival rate of S. maltophilia-HAP patients treated with montherapy and combination definitive therapy (censored at 30 d after definitive therapy). Figure legend Cox survival curves demonstrated that combination treatment was related to similar 30-day mortality risk in the overall patient cohort, patients with APACHE II scores < 15, and immunocompetent individuals, but with a decline in 30-day mortality risk among those patients with APACHE II scores ≥ 15 and immunocompromised individuals after controlling for WPS

Back to article page